Panacea Biotec

Sector: Healthcare

Followers

0
0
0
0
.
8
8
5
5
3
3
5.35 (1.52%)

As on 17 Apr, 2026 | 10:31

Open Trading A/c
Day Range
346.60
358.00
LH
52 Week Range
292.40
581.90
LH
Volume
* i
Bid / Ask
24,768.00
357.05 / 2.00

Panacea Biotec Announcements

Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication regarding notice intimating the investors about the opening of a Special Window for...

15 Apr, 2026 | 03:32pm • Source: NSE

We would like to inform you that the Company has received four Awards from the Presiding Officer (in the rank of Additional District Judge) of...

10 Apr, 2026 | 04:21pm • Source: BSE

We are enclosing herewith a certificate dated 01.04.2026, issued by Skyline Financial Services Pvt. Ltd., Registrar and Transfer Agent of the Company, confirming compliance under...

07 Apr, 2026 | 12:01pm • Source: BSE

We would like to inform you that no share has been dematerialised during the month of March 2026. A copy of the certificate obtained from...

07 Apr, 2026 | 11:57am • Source: BSE

In continuation to our letter dated 06.03.2026, we are pleased to inform you that Deputy Commissioner of Income Tax has issued a rectified Assessment Order...

07 Apr, 2026 | 11:54am • Source: BSE

In continuation to our letter dated 02.03.2026, we are pleased to inform you that the Deputy Commissioner of Income Tax has issued a rectified Assessment...

07 Apr, 2026 | 11:48am • Source: BSE

We would like to inform you that Mr. Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of...

01 Apr, 2026 | 09:43am • Source: BSE

We would like to inform you that Mr. Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of...

01 Apr, 2026 | 09:26am • Source: BSE

We would like to inform you that CA Rajesh Jain, Independent Director of the Company and its material wholly owned subsidiary, Panacea Biotec Pharma Limited...

30 Mar, 2026 | 04:53pm • Source: BSE

We would like to inform you that with respect to the appeals filed by the Company in the Office of the Commissioner of Income Tax...

27 Mar, 2026 | 05:50pm • Source: BSE

We would like to inform you that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives)...

24 Mar, 2026 | 04:27pm • Source: BSE

We are pleased to inform you that the Company''s wholly owned subsidiary, Panacea Biotec Pharma Ltd. (PBPL) has received an Order dated 10.03.2026 issued by...

11 Mar, 2026 | 02:49pm • Source: BSE

We would like to inform you that the Company has received on March 06, 2026, a Demand Order dated March 01, 2026, from the Office...

06 Mar, 2026 | 05:46pm • Source: BSE

Please find enclosed herewith demat status report for the month of February 2026.

06 Mar, 2026 | 02:17pm • Source: BSE

We would like to inform you that the Company has received on 01.03.2026, a Demand Order dated 27.02.2026, from the Office of Deputy Commissioner of...

02 Mar, 2026 | 12:41pm • Source: BSE

Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter and nine months ended 31.12.2025.

12 Feb, 2026 | 03:50pm • Source: BSE

Please find enclosed details of shares dematerialised during January 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

06 Feb, 2026 | 03:32pm • Source: BSE

Please find attached outcome of inspection by National Centre for Public Health and Pharmacy, Hungary at manufacturing facility of the Company''s material wholly owned subsidiary,...

05 Feb, 2026 | 02:52pm • Source: BSE

Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...

02 Feb, 2026 | 03:42pm • Source: BSE

We are now delighted to inform you that enrolment of study participants in context of DengiAll Phase-III clinical trial has been completed.

07 Jan, 2026 | 06:36pm • Source: BSE